| A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis (NCT00694980) | Genentech, Inc. | 2008-09-01 |
| Thalidomide in Pediatric Inflammatory Bowel Diseases. (NCT00720538) | IRCCS Burlo Garofolo | 2008-08-01 |
| Epidemiology of Ulcerative Colitis and Crohn's Disease in Non Jewish Israel Population (NCT00815061) | Rabin Medical Center | 2008-07-01 |
| (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis (NCT00679432) | Bausch Health Americas, Inc. | 2008-06-01 |
| (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis (NCT00679380) | Bausch Health Americas, Inc. | 2008-06-01 |
| Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis (NCT00702611) | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | 2008-06-01 |
| Comparison Between Chromoendoscopy and Virtual Chromoendoscopy (NBI, I-scan, FICE) for Detection of Neoplasia in Long Standing Ulcerative Colitis (NCT01882205) | Universitaire Ziekenhuizen KU Leuven | 2008-05-01 |
| Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses (NCT00663819) | W.L.Gore & Associates | 2008-04-01 |
| A Study of MDX-1100 in Subjects With Active Ulcerative Colitis (NCT00656890) | Bristol-Myers Squibb | 2008-04-01 |
| Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis (NCT00628433) | Harbor Therapeutics | 2008-02-01 |
| Vitamin D Levels in Children With IBD (NCT00621257) | Boston Children's Hospital | 2008-01-01 |
| The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis (NCT00620126) | University of Maryland, Baltimore | 2008-01-01 |
| Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness (NCT00769353) | University of Pittsburgh | 2008-01-01 |
| Methods of Improvement Adherence With Therapy in Ulcerative Colitis. (NCT00398593) | University Hospitals, Leicester | 2007-12-01 |
| Effects of Probiotics in Patients With Ulcerative Colitis (NCT00578799) | University of California, Irvine | 2007-12-01 |
| Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease (NCT00619489) | Millennium Pharmaceuticals, Inc. | 2007-12-01 |
| Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis (NCT00573794) | AbbVie (prior sponsor, Abbott) | 2007-11-28 |
| Mind/Body Medicine and IBD Flare-Up (NCT00568256) | Rush University Medical Center | 2007-11-01 |
| User Surveillance in Ulcerative Colitis (NCT01363453) | Ferring Pharmaceuticals | 2007-10-01 |
| Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical Trial (NCT00553163) | Queen Mary University of London | 2007-10-01 |
| Comparison of Methotrexate vs Placebo in Corticosteroid-dependent Ulcerative Colitis (NCT00498589) | Centre Hospitalier Universitaire de Besancon | 2007-09-01 |
| Managing Inflammatory Bowel Disease (NCT00679003) | University of Washington | 2007-09-01 |
| Cost-effectiveness of TPMT Pharmacogenetics (NCT00521950) | ZonMw: The Netherlands Organisation for Health Research and Development | 2007-09-01 |
| Oligofructose-enriched Inulin for the Treatment of Mild to Moderate Active Ulcerative Colitis (NCT02093767) | University of Alberta | 2007-08-01 |
| Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative Colitis (NCT00586599) | Indiana University | 2007-08-01 |
| Fecal Biomarker Study for Patients With Ulcerative Colitis (NCT00780507) | Warner Chilcott | 2007-08-01 |
| Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807) (NCT00537316) | Merck Sharp & Dohme LLC | 2007-07-01 |
| A Comparison of Once a Day Dose Compared to 2 Doses/Day (NCT00505778) | Warner Chilcott | 2007-07-01 |
| Ulcerative Colitis Relapse Prevention Trial, Hypnosis (NCT00798642) | Northwestern University | 2007-07-01 |
| Basiliximab Maintenance in Ulcerative Colitis (NCT01061996) | Cerimon Pharmaceuticals | 2007-07-01 |
| The Innate Immune System and Inflammatory Bowel Disease (NCT00516776) | Norwegian University of Science and Technology | 2007-06-01 |
| European Safety Registry in Ulcerative Colitis (P04808) (NCT00705484) | Merck Sharp & Dohme LLC | 2007-06-01 |
| Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis (NCT00542152) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2007-06-01 |
| Assessment of Pulmonary Involvement inUlcerative Colitis by Induced Sputum (NCT00490048) | Hillel Yaffe Medical Center | 2007-06-01 |
| A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease (NCT00606346) | Janssen Biotech, Inc. | 2007-05-31 |
| An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy (NCT00467922) | Corewell Health West | 2007-05-01 |
| Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) (NCT00446849) | Shire | 2007-05-01 |
| General Surgical Outcomes Quality Improvement Database (UH-SOCRATES) (NCT00622557) | University Hospitals Cleveland Medical Center | 2007-05-01 |
| Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis (NCT01177228) | Millennium Pharmaceuticals, Inc. | 2007-05-01 |
| Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis (NCT00403923) | University Hospitals, Leicester | 2007-04-01 |
| Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis (NCT00604422) | Medtronic - MITG | 2007-04-01 |
| Basiliximab in Moderate to Severe Ulcerative Colitis (NCT00430898) | Cerimon Pharmaceuticals | 2007-01-01 |
| Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy (NCT00867438) | Cosmo Technologies Ltd | 2007-01-01 |
| A Study of Abatacept in Patients With Active Ulcerative Colitis (NCT00410410) | Bristol-Myers Squibb | 2006-12-01 |
| Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis (NCT00385736) | Abbott | 2006-11-01 |
| A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease (NCT00409396) | Vanderbilt University | 2006-11-01 |
| Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative Colitis (NCT00408629) | Abbott | 2006-11-01 |
| The Colitis Once Daily Asacol Study (NCT00708656) | Cardiff and Vale University Health Board | 2006-10-01 |
| Open-Label Adalimumab for Ulcerative Colitis Patients (NCT00421642) | Mayo Clinic | 2006-10-01 |
| Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study (NCT00486031) | Bausch Health Americas, Inc. | 2006-10-01 |
| Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis (NCT00951548) | VSL Pharmaceuticals | 2006-10-01 |
| A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis (NCT00336492) | Centocor, Inc. | 2006-09-01 |
| Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients (NCT00347048) | Astellas Pharma Inc | 2006-09-01 |
| Once Daily Versus Conventional Dosing of Asacol in the Maintenance of Quiescent Ulcerative Colitis (NCT00343850) | University of Chicago | 2006-09-01 |
| Transition of Inflammatory Bowel Disease (IBD) Patients From Pediatric to Adult Gastroenterologist (GI) (NCT00360022) | Vanderbilt University Medical Center | 2006-08-01 |
| Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study (NCT00279435) | Facet Biotech | 2006-08-01 |
| Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients (NCT00349388) | Annette Langseder | 2006-07-01 |
| A Double Blind Study for the Treatment of Acute Ulcerative Colitis (NCT00350415) | Warner Chilcott | 2006-06-01 |
| Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis (NCT00727324) | AM-Pharma | 2006-05-01 |
| Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis (NCT00408174) | Bausch Health Americas, Inc. | 2006-05-01 |
| Propionyl-L-Carnitine in Ulcerative Colitis (NCT01026857) | sigma-tau i.f.r. S.p.A. | 2006-05-01 |
| Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) (NCT00307827) | Abbott | 2006-04-01 |
| CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis (NCT00366925) | Otsuka Frankfurt Research Institute GmbH | 2006-04-01 |
| Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis (NCT00299013) | Alizyme | 2006-03-01 |
| Therapeutic Study of ONO-4819CD for Ulcerative Colitis (NCT00296556) | Kyoto University, Graduate School of Medicine | 2006-02-01 |
| A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (NCT00279422) | Facet Biotech | 2006-02-01 |
| NBI With Magnification for Dysplasia Detection in Ulcerative Colitis (NCT00292175) | London North West Healthcare NHS Trust | 2006-02-01 |
| Protein Metabolism in Newly Diagnosed Pediatric Inflammatory Bowel Disease (NCT00586352) | Indiana University | 2006-01-01 |
| A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis (NCT00295282) | Bristol-Myers Squibb | 2006-01-01 |
| Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission (NCT00326209) | Bausch Health Americas, Inc. | 2005-12-22 |
| New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis (NCT00269438) | Bausch Health Americas, Inc. | 2005-12-01 |
| Chromoendoscopy for Ulcerative Colitis Surveillance (NCT00274209) | Indiana University | 2005-12-01 |
| Treatment With Local PPARgamma Ligand in Distal Ulcerative Colitis (NCT00309660) | Herlev Hospital | 2005-11-01 |
| A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis. (NCT00254618) | Warner Chilcott | 2005-10-01 |
| OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis (NCT00449722) | Dr. Falk Pharma GmbH | 2005-07-01 |
| The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels (NCT00167882) | Amsterdam UMC, location VUmc | 2005-07-01 |
| Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) (NCT00219414) | Otsuka Frankfurt Research Institute GmbH | 2005-06-01 |
| Metabolic Response to Infliximab in Pediatric Ulcerative Colitis (NCT00586807) | Indiana University | 2005-06-01 |
| Wireless Capsule Endoscopy in Ulcerative Colitis (NCT00145808) | University of Chicago | 2005-06-01 |
| Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission (NCT00209300) | Ferring Pharmaceuticals | 2005-05-01 |
| A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions (NCT00618202) | Roxane Laboratories | 2005-05-01 |
| Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis (NCT00151892) | Shire | 2005-04-08 |
| Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease (NCT00222378) | University of Miami | 2005-04-01 |
| Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NCT00232258) | Sanofi | 2005-04-01 |
| Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis (NCT00767728) | Bausch Health Americas, Inc. | 2004-12-01 |
| Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis (NCT00744016) | Bausch Health Americas, Inc. | 2004-12-01 |
| GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis (NCT00457171) | GlaxoSmithKline | 2004-12-01 |
| FishGastro Study: Fish Consumption and Gastro-Intestinal Health (NCT00145015) | Quadram Institute Bioscience | 2004-12-01 |
| A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients (NCT00207688) | Janssen Research & Development, LLC | 2004-08-31 |
| Study for the Treatment of Ulcerative Colitis With Adacolumn (NCT00102193) | Otsuka America Pharmaceutical | 2004-07-01 |
| Lactobacillus Acidophilus and Bifidobacterium Animalis Subsp. Lactis, Maintenance Treatment in Ulcerative Colitis (NCT00268164) | Hvidovre University Hospital | 2004-06-01 |
| CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission (NCT00092508) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2004-05-01 |
| Rituximab in Active Ulcerative Colitis (NCT00261118) | Royal Liverpool University Hospital | 2004-04-01 |
| Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease (NCT00114803) | Boston Children's Hospital | 2004-01-01 |
| Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions (NCT00618228) | Roxane Laboratories | 2004-01-01 |
| Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis (NCT00548574) | Shire | 2003-12-04 |
| Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease (NCT00215020) | Boston Children's Hospital | 2003-09-01 |
| Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia (NCT00352404) | Johannes Gutenberg University Mainz | 2003-08-01 |
| Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis (NCT01171807) | Quince Therapeutics S.p.A. | 2003-07-22 |
| Asacol Dosing Study for Active Ulcerative Colitis (NCT00194818) | University of Washington | 2003-06-01 |